• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
• 3. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
• 4. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
• 5. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090

Introduction to 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride (CAS No. 38984-68-8)

2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 38984-68-8, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This heterocyclic organic compound belongs to the thiazolidine class, characterized by a sulfur-containing five-membered ring structure. The presence of two methyl groups at the 2-position and a carboxylic acid group at the 4-position, along with its hydrochloride salt form, imparts unique chemical and pharmacological properties that make it a subject of considerable interest in medicinal research.

The structural motif of 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride lends itself to diverse applications in drug discovery and development. The thiazolidine ring is a common scaffold in biologically active molecules, often found in nonsteroidal anti-inflammatory drugs (NSAIDs), antiviral agents, and other therapeutic compounds. The carboxylic acid functionality not only influences the compound's solubility and reactivity but also serves as a potential site for further derivatization, enabling the synthesis of more complex pharmacophores.

In recent years, there has been growing interest in thiazolidine derivatives due to their demonstrated efficacy in modulating various biological pathways. For instance, studies have highlighted the potential of 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride as a precursor or intermediate in the synthesis of novel compounds with anti-inflammatory and analgesic properties. The hydrochloride salt form enhances the compound's stability and bioavailability, making it a valuable candidate for further pharmacological investigation.

One of the most compelling aspects of 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride is its role in exploring new therapeutic targets. Researchers have leveraged its structural framework to develop molecules that interact with specific enzymes or receptors implicated in diseases such as cancer, neurodegenerative disorders, and metabolic syndromes. The versatility of this compound lies in its ability to serve as a building block for designing molecules with tailored biological activities.

The synthesis of 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride typically involves multi-step organic reactions that establish the thiazolidine core and introduce the necessary functional groups. Advances in synthetic methodologies have enabled more efficient and scalable production processes, facilitating its use in both academic research and industrial applications. The compound's reactivity allows for modifications at various positions on the ring, enabling chemists to fine-tune its properties for specific applications.

From a pharmacological perspective, 2,2-dimethyl-1,3-thiazolidine-4-carboxylic acid hydrochloride has shown promise in preclinical studies as an inhibitor of certain enzymes involved in inflammation and pain signaling. Its mechanism of action may involve interactions with cyclooxygenase (COX) enzymes or other mediators of the inflammatory response. Such findings underscore its potential as a lead compound for developing next-generation therapeutics.

The compound's physicochemical properties also make it an attractive candidate for formulation development. As a hydrochloride salt, it exhibits good solubility in aqueous media, which is advantageous for preparing injectable solutions or oral formulations. This solubility profile contributes to its suitability for various administration routes and enhances patient compliance in therapeutic regimens.

In conclusion, 2 , 2 - dimethyl - 1 , 3 - thiazolidine - 4 - carboxylic acid hydrochloride ( CAS No . 38984 - 68 - 8 ) represents a significant advancement in pharmaceutical chemistry . Its unique structural features , combined with its potential biological activities , position it as a valuable asset in drug discovery efforts . As research continues to uncover new applications for this compound , it is likely to play an increasingly important role in developing innovative treatments for human diseases .

• 14347-73-0(4-Thiazolidinecarboxylicacid, 2-ethyl-)
• 16708-09-1(2,4-Thiazolidinedicarboxylicacid, 2-methyl-)
• 58166-38-4((4R)-2,2-Dimethyl-4-thiazolidinecarboxylic acid)
• 115127-64-5(4-Thiazolidinecarboxylicacid, 2-(hydroxymethyl)-, (2R-cis)- (9CI))
• 88855-02-1(4-Thiazolidinecarboxylicacid, 2-methyl-, (2S,4R)-)
• 124617-04-5(4-Thiazolidinecarboxylicacid, 2-(hydroxymethyl)-, (2S-trans)- (9CI))
• 3963-50-6(Methyl 2,2-dimethyl-1,3-thiazolidine-4-carboxylate hydrochloride)
• 4165-32-6(2-Methylthiazolidine-4-carboxylic Acid)
• 213475-47-9(4-Thiazolidinecarboxylicacid, 2,2-dimethyl-, hydrochloride (1:1), (4S)-)
• 190062-99-8(4-Thiazolidinecarboxylicacid, 2-methyl-, (4R)-)